Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Kanauchi: Advanced glycation end products in nondiabetic patients with coronary artery disease. (0.15 sec) 

Advanced glycation end products in nondiabetic patients with coronary artery disease

- diabetesjournals.org
M Kanauchi, N Tsujimoto, T Hashimoto - Diabetes Care, 2001 - Am Diabetes Assoc
RESULTS—Patients were classified into four groups based on the number of
significantly stenosed vessels, defined as 0-, 1-, 2-, or 3-vessel disease.
Serum concentrations of AGEs were significantly higher in nondiabetic ...
Cited by 55 - Related articles - BL Direct - All 7 versions

Plasma levels of soluble receptor for advanced glycation end products and coronary artery …

- ahajournals.org
C Falcone, E Emanuele, A D'Angelo, MP Buzzi, … - Arteriosclerosis, thrombosis, and vascular biology, 2005 - Am Heart Assoc
Methods and Results— Plasma levels of sRAGE were determined in 328 nondiabetic
male patients with angiographically proved CAD and in 328 age-matched healthy
controls. The concentration of sRAGE in plasma was significantly lower ...
Cited by 111 - Related articles - All 11 versions

S e rum Levels of Advanced Glycation End Products Are Increased in Patients Wi thType 2 …

- Free from Publisher
BK Kilhovd, TJ Berg, KI Birkeland, P Thorsby … - Diabetes Care, 1999 - Am Diabetes Assoc
AGEs have been suggested to participate in the development of both micro- and
macro- vascular complications in diabetes. AGE deposits have been demonstrated
in athero scle rotic plaques and myocard ium by immunohistochemistry in ...
Cited by 99 - Related articles - BL Direct - All 8 versions

The role of advanced glycation end products in the development of atherosclerosis


M Peppa, J Uribarri, H Vlassara - Current Diabetes Reports, 2004 - Springer
Introduction Cardiovascular disease (CVD) is the leading cause of morbidity and
mortality not only in the United States but also worldwide [1]. Atherosclerosis
constitutes the main pathologic substrate of CVD, and through progressive ...
Cited by 47 - Related articles - BL Direct - All 2 versions

Relationship between the-374 T/A RAGE gene polymorphism and angiographic coronary …


C Falcone, I Campo, E Emanuele, MP Buzzi, M … - International journal of molecular medicine, 2004 - cat.inist.fr
The receptor for advanced glycation end products(RAGE) is thought to play a
critical role in diabetic atherosclerosis. Accordingly, a functional-374 T/A
polymorphism in RAGE gene promoter has been associated with macrovascular ...
Cited by 32 - Related articles - BL Direct - All 6 versions

High serum levels of advanced glycation end products predict increased coronary heart …

- ahajournals.org
BK Kilhovd, A Juutilainen, S Lehto, T … - Arteriosclerosis, thrombosis, and vascular biology, 2005 - Am Heart Assoc
Methods and Results— Serum levels of AGEs were measured with an immunoassay in
samples obtained at baseline examination of a random sample of 1141 nondiabetic
individuals (535 men and 606 women), aged 45 to 64 years, living in Kuopio, ...
Cited by 36 - Related articles - All 7 versions

Immunolocalization of the Glycoxidation Product NE-(carboxymethyl) Lysine in Normal and …


ED Schleicher, KE Gempel, E Wagner, AG … - The Maillard reaction in foods and medicine, 1998 - books.google.com
Immunolocalization of the Glycoxidation Product NE-(carboxymethyl) Lysine in
Normal and Inflamed Human Intestinal Tissues Envin D. Schleicher, Klaus E.
Gempel, 1 Eva Wagner1 and Andreas G. Nerlich2 DEPARTMENT FOR INTERNAL ...
Cited by 1 - Related articles - All 2 versions

Increased serum concentrations of advanced glycation end products: a marker of coronary …

- bmj.com [PDF] 
K Kiuchi, J Nejima, T Takano, M Ohta, H … - British Medical Journal, 2001 - heart.bmj.com
K Kiuchi, J Nejima, T Takano, M Ohta, H Hashimoto and GF BAXTER ... Rapid
responses http://heart.bmj.com/cgi/eletter-submit/85/1/87 You can respond to
this article at: ... K Kiuchi, J Nejima, T Takano, M Ohta, H Hashimoto
Cited by 48 - Related articles - BL Direct - All 5 versions

Glucose metabolism and coronary heart disease in patients with normal glucose tolerance


FC Sasso, O Carbonara, R Nasti, B Campana, R … - JAMA, 2004 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better.
Cited by 64 - Related articles - BL Direct - All 5 versions

The advanced glycation end product Nepsilon-(carboxymethyl) lysine is increased in serum …

- diabetesjournals.org [PDF] 
TJ Berg, JT Clausen, PA Torjesen, K Dahl- … - Diabetes Care, 1998 - Am Diabetes Assoc
F rom the Aker Diabetes Research Center (TJB, KD-J., H.-JB, KFH) and the Hormone
Laboratory (P. A . T. ) , Aker University Hospital, Oslo, Norway; and Novo
Nordisk (JTC), Bagsvaerd, Denmark. A dd ress correspondence and reprint ...
Cited by 55 - Related articles - All 8 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google